Vaishali Sanchorawala @vsanchorawala

Director, Amyloidosis Center @BU_Amyloidosis Hematologist and Oncologist @The_BMC bu.edu/amyloid Boston Joined October 2015

Tweets

2K
Followers

3K
Following

551
Likes

10K

The International Society Of Amyloidosis @ISA_Amyloidosis

a week ago

Planning to attend the 2026 International Symposium on Amyloidosis in Montevideo? Plan time to explore Uruguay! Discover more: isaamyloidosis.org #ISA2026 #Amyloidosis #VisitUruguay

1 7 8 519 0

Download Video

Vaishali Sanchorawala @vsanchorawala

2 weeks ago

This case report highlights that accurate diagnosis of amyloidosis relies on advanced testing and a multidisciplinary approach. @BU_Amyloidosis Wild-Type Transthyretin Amyloidosis in the Kidneys sciencedirect.com/science/articl…

2 7 16 1K 3

Vaishali Sanchorawala @vsanchorawala

a month ago

Teclistamab therapy for refractory type 1 cryoglobulinemia | Haematologica haematologica.org/article/view/1…

0 1 9 573 2

Vaishali Sanchorawala @vsanchorawala

a month ago

Kidney transplantation in PCDs is now a real option for select patients with ESKD due to MM, AL amyloidosis, or MGRS. A multidisciplinary panel reviews evolving evidence, challenges, and opportunities in this life-changing therapy. @BU_Amyloidosis kidney-international.org/article/S0085-…

2 23 51 3K 11

The International Society Of Amyloidosis @ISA_Amyloidosis

a month ago

Applications are now open for the 2026–2027 Amyloidosis Fellowship Program! - Applicants must hold an MD or equivalent - Joint application with a qualifying host institution required - Deadline: October 31, 2025 Apply early: isaamyloidosis.org/fellowships/

1 4 7 470 2

Download Image

BU Amyloidosis Center @BU_Amyloidosis

2 months ago

Proud to host our Clinical Multidisciplinary Amyloidosis Center meeting—bringing together brilliant minds from hematology, cardiology, nephrology, genetic counseling, rheumatology and nursing. 🙌 Together, we are advancing care and standing by every patient facing amyloidosis!

3 2 17 840 1

Download Image

Vaishali Sanchorawala @vsanchorawala

2 months ago

The Phase III CARES trial of #anselamimab in #ALAmyloidosis did not meet its primary endpoint, but showed clinically meaningful benefit in a predefined high-risk subgroup. More details to follow at upcoming meetings. @BU_Amyloidosis astrazeneca.com/media-centre/p…

1 12 28 3K 1

The International Society Of Amyloidosis @ISA_Amyloidosis

2 months ago

Save the date for the the 2026 International Symposium on Amyloidosis! Join leading clinicians, researchers, and scientists from around the globe at the premier meeting dedicated to amyloidosis and protein-folding diseases. Stay tuned for more details: isaamyloidosis.org/isa-symposium/

0 16 26 2K 3

Download Image

Amyloidosis Speakers Bureau @Amyloidosis_ASB

2 months ago

Diagnosing amyloidosis can be tricky. So what if your patient actually has more than 1 type of amyloidosis? pubmed.ncbi.nlm.nih.gov/40526008/ "Our findings underscore the complexity of clinical presentation in amyloidosis, as multiple amyloid types can co-exist in a single individual and…

0 6 10 488 2

Vaishali Sanchorawala @vsanchorawala

2 months ago

Honored to be named a 2025 Hematology Research All-Star! This recognition by @avant-garde Health highlights the top 5% of physicians for impactful research. Grateful to my collaborators and mentors, this is a shared achievement! @BU_Amyloidosis @The_BMC @BUMedicine

6 8 68 5K 2

BU Amyloidosis Center @BU_Amyloidosis

2 months ago

Remembering Dr. David Seldin June 27 marks 10 years since the passing of Dr. David Seldin - a visionary leader in amyloidosis research, a dedicated mentor, and a beloved colleague. His legacy continues to inspire our work every day.

3 3 18 593 0

Download Image

BU Amyloidosis Center @BU_Amyloidosis

2 months ago

Our latest study highlights the clinical complexity of dual amyloidosis, where multiple amyloid types can coexist in the same patient across different organs. Accurate fibril typing is essential for diagnosis and treatment. pubmed.ncbi.nlm.nih.gov/40526008/

0 4 9 524 1

Vaishali Sanchorawala @vsanchorawala

2 months ago

Our findings highlight the complexity of amyloidosis, with multiple amyloid types potentially co-existing in a single individual and involving diverse anatomical sites. @BU_Amyloidosis The Amyloidosis Intersection: Dual Amyloid Types in a Single Host pubmed.ncbi.nlm.nih.gov/40526008/

3 6 29 1K 2

Amyloidosis Speakers Bureau @Amyloidosis_ASB

3 months ago

NEW PODCAST EPISODE HAS DROPPED! youtu.be/FmY3HwRyfXM?si… In today’s episode we’ll be talking about genetic counseling for those impacted by hereditary amyloidosis. This topic is important for patients who have one of the more than 130 types of genetic variants of hereditary…

1 4 17 536 2

Download Image

BU Amyloidosis Center @BU_Amyloidosis

3 months ago

Excited to share our latest conversation on genetic counseling by Lucas Pereira, clinical genetic counselor at @BU_Amyloidosis; thought-provoking, insightful, and not to be missed! 🎙️ Listen now: youtube.com/watch?v=FmY3Hw…

0 2 6 955 0

Vaishali Sanchorawala @vsanchorawala

4 months ago

Comprehensive, multidimensional geriatric assessment is essential in managing cardiac amyloidosis. Frailty, functional status, cognition, and social support must be integrated into care planning to optimize outcomes. @BU_Amyloidosis pubmed.ncbi.nlm.nih.gov/40373524/

0 1 8 498 4

Abdulla A. Damluji, MD, PhD @DrDamluji

4 months ago

Cardiac Amyloidosis in Older Adults With a Focus on Frailty: JACC: Advances Expert Consensus: @JACCJournals 🥸 @DrAROrkaby introduced me to @DrNikkiBart - and this turned out to be a great project 😱From @ACCinTouch geriatric cardiology leadership council: Summary 👇👇👇